Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021

The varicose vein treatment market in North America and Europe is projected to reach to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, growing at a CAGR of 6.9% from 2016 to 2021.

Objectives of the study are:

• To define, describe, and forecast the varicose vein treatment market in North America and Europe on the basis of mode of treatment, products, and regions
• To provide detailed information regarding major factors influencing the growth of the varicose vein treatment market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile the key players and comprehensively analyze their market shares
• To estimate and forecast the varicose vein treatment market by mode and product in North America (U.S. and Canada) and Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)

Research Methodology

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations.

To know about the assumptions considered for the study, download the pdf brochure

As of 2015, Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), and biolitec AG (Austria) are some of the key players of the varicose vein treatment market in North America and Europe. Major market players were witnessed to adopt organic as well as (new product launches) as well as inorganic growth strategies (acquisitions and agreements) to enhance their market shares and positions during 2013-2016; with new product launch being the most-prominent growth strategy adopted by majority of market players. Several market players also pursued the strategy of strategic acquisitions to strengthen their market positions and enhance their R&D capabilities.

Stakeholders

• Varicose vein treatment product manufacturers, vendors, and distributors
• Research institutes and government organizations
• Venture capitalists and other government funding organizations
• Research and consulting firms
• Healthcare institutions (hospitals and medical schools)
• Pharmaceutical and biotechnology companies

Scope of the Report

This research report categorizes the varicose vein treatment market in North America and Europe into the following segments and subsegments:

Market, by Treatment Mode

• Endovenous Ablation
• Injection Sclerotherapy
• Surgical Ligation/Stripping

Market, by Products

• Ablation Devices
• Radiofrequency Ablation Devices
• Laser Ablation Devices
• Venous Closure Products

Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

• Product Matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

• Analysis of the market in the Asia-Pacific or the Rest of the World regions

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1. Introduction
     1.1 Objectives of the Study
     1.2 Market Definition
     1.3 Market Scope
            1.3.1 Markets Covered
            1.3.2 Geographic Scope
            1.3.3 Years Considered for the Study

2.Research Methodology
     2.1 Research Data
            2.1.1 Secondary Data
            2.1.2 Primary Data
     2.2 Market Size Estimation Models
     2.3 Market Size Estimation Steps
     2.4 Market Breakdown and Data Triangulation
     2.5 Research Assumptions

3. Executive Summary
     3.1 Introduction
     3.2 Snapshot of Market in North America and Europe

4. Market Dynamics
     4.1 Market Segmentation
     4.2 Overview
     4.3 Key Market Drivers
     4.4 Key Market Restraints
     4.5 Key Market Opportunities
     4.6 Key Market Challenges

5. Varicose Vein Treatment Market in North America and Europe, By Treatment Mode
     5.1 Introduction
     5.2 Endovenous Ablation
     5.3 Injection Sclerotherapy
     5.4 Surgical Ligation/Stripping

6. Varicose Vein Treatment Market in North America and Europe, By Product
     6.1 Introduction
     6.2 Ablation Devices
            6.2.1 Radiofrequency Ablation Devices
            6.2.2 Laser Ablation Devices
     6.3 Venous Closure Products
     6.4 Surgical Products

7. Varicose Vein Treatment Market, By Region
     7.1 Introduction
     7.2 North America
            7.2.1 U.S.
            7.2.2 Canada
     7.3 Europe
            7.3.1 Germany
            7.3.2 France
            7.3.3 U.K.
            7.3.4 Italy
            7.3.5 Spain
            7.3.6 Rest of Europe (RoE)

8. Competitive Landscape
     8.1 Introduction
     8.2 Market Share Analysis
     8.3 Competitive Scenario
     8.4 Recent Developments
            8.4.1 New Product Launches
            8.4.2 Acquisitions
            8.4.3 Agreements
            8.4.4 Other Developments

9. Company Profiles
     9.1 Introduction
            9.1.1 Geographic Benchmarking
     9.2 Angiodynamics, Inc. (U.S.)
     9.3 Medtronic, PLC (U.S.)
     9.4 Biolitec Ag (Austria)
     9.5 Syneron Medical Ltd. (Israel)
     9.6 Lumenis Ltd. (Israel)

10. Appendix
      10.1 Discussion Guide
      10.2 Introducing RT: Real-Time Market Intelligence
      10.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
      10.4 Available Customizations
      10.5 Related Reports
 

List of Tables (67 Tables)

Table - 1 Prevalence of Varicose Veins in the European Region
Table – 2 Prevalence of Primary Varicose Veins in European Region (2013) (Thousand)
Table – 3 Reimbursement Scenario for Varicose Vein Treatments in Europe, By Country
Table – 4 Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 5 Varicose Vein Treatment Modes Market Size, By Region, 2014–2021 (USD Million)
Table – 6 Varicose Vein Treatment Modes Market Size (USD Million) and Market Share (%), By Country, 2016
Table – 7 North America: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 8 Europe: Varicose Vein Treatment Modes Market Size, By Country, 2014–2021 (USD Million)
Table – 9 Endovenous Ablation Market Size, By Region, 2014–2021 (USD Million)
Table – 10 North America: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 11 Europe: Endovenous Ablation Market Size, By Country, 2014–2021 (USD Million)
Table – 12 Injection Sclerotherapy Market Size, By Region, 2014–2021 (USD Million)
Table – 13 North America: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 14 Europe: Injection Sclerotherapy Market Size, By Country, 2014–2021 (USD Million)
Table – 15 Surgical Ligation/Stripping Market Size, By Region, 2014–2021 (USD Million)
Table – 16 North America: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 17 Europe: Surgical Ligation/Stripping Market Size, By Country, 2014–2021 (USD Million)
Table – 18 Market Size, By Product, 2014–2021 (USD Million)
Table – 19 Varicose Vein Treatment Product Market Size, By Region, 2014–2021 (USD Million)
Table – 20 North America: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 21 Europe: Varicose Vein Treatment Product Market Size, By Country, 2014–2021 (USD Million)
Table – 22 Varicose Vein Treatment Ablation Devices Market Size, By Type, 2014–2021 (USD Million)
Table – 23 Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 24 North America: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 25 Europe: Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 26 Radiofrequency Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 27 North America: Radiofrequency Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 28 Laser Ablation Devices Market Size, By Region, 2014–2021 (USD Million)
Table – 29 North American Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 30 North America: Laser Ablation Devices Market Size, By Country 2014–2021 (USD Million)
Table – 31 Europe: Laser Ablation Devices Market Size, By Country, 2014–2021 (USD Million)
Table – 32 Venous Closure Products Market Size, By Region, 2014–2021 (USD Million)
Table – 33 North America: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 34 Europe: Venous Closure Products Market Size, By Country, 2014–2021 (USD Million)
Table – 35 Surgical Products Market Size, By Region, 2014–2021 (USD Million)
Table – 36 North America: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 37 Europe: Surgical Products Market Size, By Country, 2014–2021 (USD Million)
Table – 38 Market Size, By Region, 2014-2021 (USD Million)
Table – 39 Market Size, By Country 2014-2021 (USD Million)
Table – 40 North America: Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 41 North America: Market Size, By Country, 2014-2021 (USD Million)
Table – 42 North America: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 43 North America: Market Size, By Product, 2014-2021 (USD Million)
Table – 44 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 45 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table – 46 Canada: Varicose Vein Treatment Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 47 Canada: Varicose Vein Treatment Market Size, By Product, 2014-2021 (USD Million)
Table – 48 Europe: Varicose Vein Treatment Market Size, By Country and Treatment Mode, 2016 (USD Million)
Table – 49 Europe: Varicose Vein Treatment Market Size, By Country, 2014-2021 (USD Million)
Table – 50 Europe: Varicose Vein Treatment Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table – 51 Europe: Varicose Vein Treatment Market Size, By Product, 2014-2021 (USD Million)
Table – 52 Germany: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 53 Germany: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 54 France: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 55 France: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 56 U.K.: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 57 U.K.: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 58 Italy: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 59 Italy: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 60 Spain: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 61 Spain: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 62 Rest of Europe: Varicose Vein Treatment Market Size, By Treatment Mode, 2014–2021 (USD Million)
Table – 63 Rest of Europe: Varicose Vein Treatment Market Size, By Product, 2014–2021 (USD Million)
Table – 64 New Product Launches (2013–2016) (CNTD…)
Table – 65 Acquisitions (2013-2016)
Table – 66 Agreements (2013-2016)
Table – 67 Other Developments (2013-2016)

List of Figures (19 Figures)

Figure-1 Research Design
Figure-2 Breakdown of Primary Interviews: By Company Type, Designation, & Country
Figure-3 North American Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-4 European Market, By Country: Market Share (2016) and CAGR (2016–2021)
Figure-5 Healthcare Expenditures as Percentage of GDP in Major European Countries
Figure-6 Key Markets: Changing Proportion of Geriatric Individuals (Aged 65 Years and Above) in Total Population (2020 vs. 2030)
Figure-7 Market Share, By Product (2016–2021) (USD Million)
Figure-8 North America: Market, By Mode of Treatment, 2016 (%)
Figure-9 North America: Varicose Vein Treatment Market Share, By Country (2016 vs. 2021)
Figure-10 North America: Varicose Vein Treatment Market Share, By Mode of Treatment, 2016
Figure-11 Europe: Varicose Vein Treatment Market, By Mode of Treatment, 2016 (USD Million)
Figure-12 Europe: Varicose Vein Treatment Market Share, By Country (2016 vs. 2021)
Figure-13 EU-5: Market Share, By Mode of Treatment, 2016
Figure-14 Leading Market Players Adopted Product Development and Commercialization as Key Growth Strategies During 2012-2015
Figure-15 Market Share, By Key Player (2015)
Figure-16 Product Development, the Most Widely Adopted Growth Strategy During 2013-2016
Figure-17 Geographic Benchmarking
Figure-18 Marketsandmarkets Knowledge Store Snapshot
Figure-19 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot 

The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the Varicose Vein Treatment market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of Varicose Vein Treatment market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the Varicose Vein Treatment market.

This report broadly segments the Varicose Vein Treatment market into mode of treatment and products. On the basis of mode of treatment, the Varicose Vein Treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the Varicose Vein Treatment market, by mode of treatment, in 2016.

Based on type of products, the Varicose Vein Treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

This report covers the Varicose Vein Treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

To speak to our analyst for a discussion on the above findings, click Speak to Analyst